ACCESSION: MSBNK-SMB_Measured-HSA015P0205004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'EL06_pos_3297': {'bp': 554094.0, 'sum': 1418696.0}, 'EL12_pos_3297': {'bp': 460039.0, 'sum': 1298157.0}, 'EL01_pos_3296': {'bp': 456270.0, 'sum': 1237610.0}, 'EL02_pos_3309': {'bp': 343908.0, 'sum': 1217480.0}, 'EL05_pos_3305': {'bp': 341811.0, 'sum': 1055801.0}, 'EL11_pos_3291': {'bp': 333114.0, 'sum': 927101.0}, 'EL13_pos_3299': {'bp': 306333.0, 'sum': 896500.0}, 'EL09_pos_3291': {'bp': 291472.0, 'sum': 905119.0}, 'EL10_pos_3292': {'bp': 291083.0, 'sum': 864256.0}, 'EL03_pos_3399': {'bp': 278162.0, 'sum': 892948.0}, 'EL07_pos_3285': {'bp': 273036.0, 'sum': 853831.0}, 'EL08_pos_3286': {'bp': 264495.0, 'sum': 821655.0}, 'EL14_pos_3311': {'bp': 257664.0, 'sum': 766977.0}, 'EL04_pos_3292': {'bp': 247144.0, 'sum': 784397.0}, 'EL16_pos_3297': {'bp': 222125.0, 'sum': 746121.0}, 'EL24_pos_3303': {'bp': 210184.0, 'sum': 741851.0}, 'EL23_pos_3305': {'bp': 198327.0, 'sum': 702822.0}, 'EL18_pos_3299': {'bp': 179375.0, 'sum': 605439.0}}
COMMENT: RETENTION_TIME_STDEV 0.028
COMMENT: PRECURSOR_M/Z_RAW 205.097371
COMMENT: PRECURSOR_M/Z_STDEV 0.000046
COMMENT: PRECURSOR_IN_MS1 mz 205.097153; int 73.182; delta(ppm) 1.075514
COMMENT: PROPOSED_CHARGE_STATE +1; mz 206.100687; int 8.142; cor 0.922
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 227.079195; int 5.559; cor 0.836
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 227.079195; int 5.559; cor 0.836
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.010; C11H12N2O2; [M+H]+; delta(ppm) -0.009800
COMMENT: PROPOSED_MF SevenGoldenRules 4.146; C7H19O3P; [M+Na]+; delta(ppm) 4.145893
COMMENT: PROPOSED_MF MS-FINDER 4.241; C11H12N2O2; [M+H]+; delta(ppm) -0.010110
COMMENT: PROPOSED_MF MS-FINDER 2.067; C7H19O3P; [M+Na]+; delta(ppm) 45828.670876
COMMENT: PROPOSED_MF MS-FINDER 1.972; C4H12N8S; [M+H]+; delta(ppm) -3.353882
COMMENT: PROPOSED_MF SIRIUS5_Sirius 38.399; C11H12N2O2; [M+H]+; delta(ppm) -0.010110
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.583; C9H17O3P; [M+H]+; delta(ppm) -8.063627
COMMENT: PROPOSED_MF SIRIUS5_Sirius 20.030; C10H17ClO2; [M+H]+; delta(ppm) -104766.209681
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H12N2O2; [M+H]+; delta(ppm) -0.010110
COMMENT: PROPOSED_MF SIRIUS6_Sirius 49.811; C11H12N2O2; [M+H]+; delta(ppm) -0.010110
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.742; C8H13FN2O3; [M+H]+; delta(ppm) -5.581360
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.133; C9H10N5O; [M+H]+; delta(ppm) 6.536409
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.680; C7H15N3O2P; [M+H]+; delta(ppm) -1.517213
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.809; C10H17ClO2; [M+H]+; delta(ppm) -104766.209681
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.450; C9H17O3P; [M+H]+; delta(ppm) -8.063627
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.823; C8H15ClN3O; [M+H]+; delta(ppm) -104760.963019
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.771; C6H15FN2O3; [M+Na]+; delta(ppm) 45831.385918
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.738; C5H13N6OP; [M+H]+; delta(ppm) 5.029286
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.922; C4H16N5OS; [M+Na]+; delta(ppm) 45826.662000
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.270; C14H14; [M+Na]+; delta(ppm) 45816.026917
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.671; C9H13FN3; [M+Na]+; delta(ppm) 45817.093519
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.116; C6H13ClN6; [M+H]+; delta(ppm) -104755.716296
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.977; C4H12N8S; [M+H]+; delta(ppm) -3.353882
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.176; C2H14N8S; [M+Na]+; delta(ppm) 45833.822279
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.657; C10H17NP; [M+Na]+; delta(ppm) 45814.378551
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H15FN2O3; [M+Na]+; delta(ppm) 45831.385918
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.978; C11H12N2O2; [M+H]+; delta(ppm) -0.010110
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.022; C8H13FN2O3; [M+H]+; delta(ppm) -5.581360
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.758; MXAUKXXHSHERRL-UHFFFAOYNA-N; [M+H]+; OC1NCCC2=C1NC1=CC=C(O)C=C21
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.749; LNHYOBLZAGKVCY-LDGXTIHJNA-N; [M+H]+; O[C@H]1N2CCCC2=[N+]([O-])C2=C1C=CC=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.748; KEKBLIAQVPGFMT-UHFFFAOYSA-N; [M+H]+; O=C(OC1=NN(C=2C=CC=CC2)CC1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.715; LUOCZSSCKBGSBD-UHFFFAOYSA-N; [M+H]+; OC=1C=CC2=C(N=C3N(C2)CCC3O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.689; IGPJOUIOWWRVIN-UEQNJFAPNA-N; [M+H]+; O[C@@H]1CCN2CC3=C(C=CC=C3)[N+]([O-])=C12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.644; QIVBCDIJIAJPQS-VIFPVBQESA-N; [M+H]+; L-Tryptophan
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.795; SKVPTPMWXJSBTF-UHFFFAOYSA-N; [M+H]+; 4-Hydroxyantipyrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.742; WEFMOGRHGUPGMA-UEQNJFAPNA-N; [M+H]+; Vasicinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.726; WIMRYHOZLBQVIW-UHFFFAOYSA-N; [M+H]+; 2-[(1,2,3,4-tetrahydroquinolin-2-ylidene)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.699; KPYXDIVTPWLGHB-UEQNJFAPNA-N; [M+H]+; UNPD194902
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.689; IGPJOUIOWWRVIN-UEQNJFAPNA-N; [M+H]+; UNPD144771
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.650; LNHYOBLZAGKVCY-LDGXTIHJNA-N; [M+H]+; UNPD180829
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.620; RDTOURARQPNLFK-UHFFFAOYSA-N; [M+H]+; 2-amino-3-(3H-indol-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.615; JBJKAGOWIZGVTR-UHFFFAOYSA-N; [M+H]+; 3-Hydroxymethylantipyrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.612; KYNMONSTYCGIDJ-VIFPVBQESA-N; [M+H]+; Isotryptophan
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.585; LUOCZSSCKBGSBD-UHFFFAOYSA-N; [M+H]+; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazoline-3,6-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.567; MXAUKXXHSHERRL-UHFFFAOYNA-N; [M+H]+; 1,6-Dihydroxy-1,2,3,4-tetrahydro-beta-carboline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.567; CSZOHYLMFSLLFZ-UHFFFAOYSA-N; [M+H]+; CNP0429742
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.550; KEKBLIAQVPGFMT-UHFFFAOYSA-N; [M+H]+; 1-phenyl-4,5-dihydro-1H-pyrazol-3-yl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.513; UDTWZFJEMMUFLC-UHFFFAOYNA-N; [M+H]+; Nirvanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.498; UHOSDVKGUPVFLL-UHFFFAOYSA-N; [M+H]+; CNP0445679
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.462; YPWANZCXVOBHHZ-OIBJUYFYSA-N; [M+H]+; UNPD211811
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.456; SZQIFWWUIBRPBZ-UHFFFAOYSA-N; [M+H]+; Ethotoin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.455; HVGYHDAURCWJGF-VIFPVBQESA-N; [M+H]+; L-tryptophanyl radical cation
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.441; ITGCPUVLXUYSOK-XWIRWTPLNA-N; [M+H]+; 11-Oxocytisine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.412; ZCZGFAAEKJPNPI-UHFFFAOYSA-N; [M+H]+; 1,5-dimethyl-3-oxidooxy-2-phenylpyrazol-2-ium
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; PVVTWNMXEHROIA-UHFFFAOYSA-N; [M+H]+; Pegamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.393; SMIJAWYJFPXOAT-UHFFFAOYSA-N; [M+H]+; 2-(ethylamino)-5-phenyl-1,3-oxazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.383; UGBXGEPGAPVHGY-UHFFFAOYSA-N; [M+H]+; 3-[(dimethylamino)methylidene]-5-hydroxy-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.372; RXOIEVSUURELPG-UHFFFAOYNA-N; [M+H]+; fenozolone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.337; UZOJHXFWJFSFAI-IMWMWJONNA-N; [M+H]+; UNPD95785
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.336; JEJITTKZWUYXKM-UHFFFAOYSA-N; [M+H]+; 2-(2-hydroxyphenyl)-1,5-dimethylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.329; UDUWINCMIJQMRI-UHFFFAOYSA-N; [M+H]+; UNPD173342
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.322; WBGHUVVRWWHCDW-UHFFFAOYSA-N; [M+H]+; (4E)-4-(Nitromethylidene)-1,2,3,5-tetrahydro-3-benzazepine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.320; LHDZEMJXRKBOEB-UHFFFAOYSA-N; [M+H]+; 2-(4-hydroxyphenyl)-1,5-dimethylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.302; HPMRFMKYPGXPEP-UHFFFAOYNA-N; [M+H]+; idazoxan
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.244; RAGSBUDIXSABRI-UHFFFAOYSA-N; [M+H]+; 1-benzyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.236; FHYQNLDFRUPJAP-JLDDOWRYNA-N; [M+H]+; UNPD75564
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.210; CGSKTFVSAVYFAX-UHFFFAOYSA-N; [M+H]+; 2-acetamido-3-phenylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.158; ZLCHKGJHNUULJZ-UHFFFAOYSA-N; [M+H]+; 1-[methyl(phenyl)amino]pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.144; DLHWPLFJAJCANU-UHFFFAOYSA-N; [M+H]+; 5-oxo-N-phenylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.056; BGWJSTZPSPZPFY-UHFFFAOYSA-N; [M+H]+; 6,7-dimethoxy-2-methylquinoxaline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZCZGFAAEKJPNPI-UHFFFAOYSA-N; [M+H]+; 1,5-dimethyl-3-oxidooxy-2-phenylpyrazol-2-ium
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.963; JBJKAGOWIZGVTR-UHFFFAOYSA-N; [M+H]+; 3-Hydroxymethylantipyrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.918; KEKBLIAQVPGFMT-UHFFFAOYSA-N; [M+H]+; 1-phenyl-4,5-dihydro-1H-pyrazol-3-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.916; UDUWINCMIJQMRI-UHFFFAOYSA-N; [M+H]+; UNPD173342
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.911; JEJITTKZWUYXKM-UHFFFAOYSA-N; [M+H]+; 2-(2-hydroxyphenyl)-1,5-dimethylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.911; LHDZEMJXRKBOEB-UHFFFAOYSA-N; [M+H]+; 2-(4-hydroxyphenyl)-1,5-dimethylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.905; UHOSDVKGUPVFLL-UHFFFAOYSA-N; [M+H]+; CNP0445679
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.903; UGBXGEPGAPVHGY-UHFFFAOYSA-N; [M+H]+; 3-[(dimethylamino)methylidene]-5-hydroxy-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.883; CSZOHYLMFSLLFZ-UHFFFAOYSA-N; [M+H]+; CNP0429742
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.878; CGSKTFVSAVYFAX-UHFFFAOYSA-N; [M+H]+; 2-acetamido-3-phenylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.868; SZQIFWWUIBRPBZ-UHFFFAOYSA-N; [M+H]+; Ethotoin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; WIMRYHOZLBQVIW-UHFFFAOYSA-N; [M+H]+; 2-[(1,2,3,4-tetrahydroquinolin-2-ylidene)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.861; UZOJHXFWJFSFAI-IMWMWJONNA-N; [M+H]+; UNPD95785
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.856; RAGSBUDIXSABRI-UHFFFAOYSA-N; [M+H]+; 1-benzyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; DLHWPLFJAJCANU-UHFFFAOYSA-N; [M+H]+; 5-oxo-N-phenylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.848; SKVPTPMWXJSBTF-UHFFFAOYSA-N; [M+H]+; 4-Hydroxyantipyrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.846; IGPJOUIOWWRVIN-UEQNJFAPNA-N; [M+H]+; UNPD144771
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.842; YPWANZCXVOBHHZ-OIBJUYFYSA-N; [M+H]+; UNPD211811
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.842; ITGCPUVLXUYSOK-XWIRWTPLNA-N; [M+H]+; 11-Oxocytisine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.838; SMIJAWYJFPXOAT-UHFFFAOYSA-N; [M+H]+; 2-(ethylamino)-5-phenyl-1,3-oxazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.836; KPYXDIVTPWLGHB-UEQNJFAPNA-N; [M+H]+; UNPD194902
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.835; RXOIEVSUURELPG-UHFFFAOYNA-N; [M+H]+; fenozolone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.835; UDTWZFJEMMUFLC-UHFFFAOYNA-N; [M+H]+; Nirvanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.829; HVGYHDAURCWJGF-VIFPVBQESA-N; [M+H]+; L-tryptophanyl radical cation
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.815; ZLCHKGJHNUULJZ-UHFFFAOYSA-N; [M+H]+; 1-[methyl(phenyl)amino]pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.812; WEFMOGRHGUPGMA-UEQNJFAPNA-N; [M+H]+; Vasicinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.812; LUOCZSSCKBGSBD-UHFFFAOYSA-N; [M+H]+; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazoline-3,6-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.810; PVVTWNMXEHROIA-UHFFFAOYSA-N; [M+H]+; Pegamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.809; RDTOURARQPNLFK-UHFFFAOYSA-N; [M+H]+; 2-amino-3-(3H-indol-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.806; FHYQNLDFRUPJAP-JLDDOWRYNA-N; [M+H]+; UNPD75564
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.805; MXAUKXXHSHERRL-UHFFFAOYNA-N; [M+H]+; 1,6-Dihydroxy-1,2,3,4-tetrahydro-beta-carboline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.785; QIVBCDIJIAJPQS-VIFPVBQESA-N; [M+H]+; L-Tryptophan
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.785; KYNMONSTYCGIDJ-VIFPVBQESA-N; [M+H]+; Isotryptophan
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.746; LNHYOBLZAGKVCY-LDGXTIHJNA-N; [M+H]+; UNPD180829
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.683; WBGHUVVRWWHCDW-UHFFFAOYSA-N; [M+H]+; (4E)-4-(Nitromethylidene)-1,2,3,5-tetrahydro-3-benzazepine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.618; HPMRFMKYPGXPEP-UHFFFAOYNA-N; [M+H]+; idazoxan
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.479; BGWJSTZPSPZPFY-UHFFFAOYSA-N; [M+H]+; 6,7-dimethoxy-2-methylquinoxaline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.794; QIVBCDIJIAJPQS-VIFPVBQESA-N; [M+H]+; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.673; SZQIFWWUIBRPBZ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5-phenylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.291; UDTWZFJEMMUFLC-UHFFFAOYSA-N; [M+H]+; 5-ethyl-5-phenylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.291; RXOIEVSUURELPG-UHFFFAOYSA-N; [M+H]+; 2-ethylimino-5-phenyl-1,3-oxazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.285; CUFPYJFLBNZMOA-UHFFFAOYSA-N; [M+H]+; 3-propyl-1H-quinazoline-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.235; HPMRFMKYPGXPEP-UHFFFAOYSA-N; [M+H]+; 2-(2,3-dihydro-1,4-benzodioxin-3-yl)-4,5-dihydro-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; KZEJQPGHFLYWOJ-UHFFFAOYSA-N; [M+H]+; N-(3-oxo-1,4-dihydroisoquinolin-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; AWQPZXNYDGBBOU-KHAMKPBVSA-N; [M+H]+; (E)-4-hydroxy-3-phenyldiazenylpent-3-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; UUQQGGWZVKUCBD-UHFFFAOYSA-N; [M+H]+; [4-(hydroxymethyl)-2-phenyl-1H-imidazol-5-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; SKVPTPMWXJSBTF-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-1,5-dimethyl-2-phenylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; JBJKAGOWIZGVTR-UHFFFAOYSA-N; [M+H]+; 5-(hydroxymethyl)-1-methyl-2-phenylpyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; KZPRCESDIPAEAE-UHFFFAOYSA-N; [M+H]+; 3-phenyldiazenylpentane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; JRXGAWVXJUVHTD-UHFFFAOYSA-N; [M+H]+; 3-(2-hydroxyethyl)-2-methylquinazolin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; FKIQEBMKCDEDBS-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-oxo-3,4-dihydro-1H-1,5-benzodiazepine-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; LZIUHZARISAQQQ-UHFFFAOYSA-N; [M+H]+; 4-(4-aminophenyl)piperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; ZSSKWJBFJFCWDX-UHFFFAOYSA-N; [M+H]+; 4-(3-aminophenyl)piperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; MAUIJSRGENXQBY-UHFFFAOYSA-N; [M+H]+; 3-(4-aminophenyl)-3-methylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; QIUFCOSAUFJKSH-UHFFFAOYSA-N; [M+H]+; 6-(2-methylphenyl)-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; ZBXHHZFMTRYXCG-UHFFFAOYSA-N; [M+H]+; 3-(2-methylbenzimidazol-1-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; YCDLZRNCWDUXPK-UHFFFAOYSA-N; [M+H]+; 4-propanoyl-1,3-dihydroquinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; FSWUHNJXLGYKCJ-UHFFFAOYSA-N; [M+H]+; 2-(5,6-dimethylbenzimidazol-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; IXIODNUPYPVUBO-UHFFFAOYSA-N; [M+H]+; [3-(2-methoxyphenyl)-1H-pyrazol-5-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; UFSQOUQSBQLCPI-UHFFFAOYSA-N; [M+H]+; 2-(2,6-dimethylimidazo[1,2-a]pyridin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; HOZQRLDSYOOAJM-UHFFFAOYSA-N; [M+H]+; 3-(4-methylphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; IHVAWDKGYTYBBR-UHFFFAOYSA-N; [M+H]+; 2-(4,6-dimethyl-1H-benzimidazol-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; ISKLKIWPGSGBNF-UHFFFAOYSA-N; [M+H]+; 2-(5-methoxy-1H-indol-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; UGBXGEPGAPVHGY-RMKNXTFCSA-N; [M+H]+; (3E)-3-(dimethylaminomethylidene)-5-hydroxy-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; ZNSOPPVIOVDORC-UHFFFAOYSA-N; [M+H]+; 4-(5-methyl-3,4-dihydropyrazol-2-yl)benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; QZCFVHVWQOHXHZ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-N'-hydroxy-1-benzofuran-2-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; OTQKJRWGUZUOHM-UHFFFAOYSA-N; [M+H]+; 5-amino-N-methyl-2-prop-2-ynoxybenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; CXSJDWWAFALWCH-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-phenyl-1-prop-2-ynoxyurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; YQPIEGXNDOSVOM-UHFFFAOYSA-N; [M+H]+; 3-indazol-1-yl-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; UAYIYEKRCXWKAR-UHFFFAOYSA-N; [M+H]+; 4-(hydroxymethyl)-3-phenyl-4,5-dihydro-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; NIIJKDXDTQPYOQ-UHFFFAOYSA-N; [M+H]+; 3-(benzimidazol-1-yl)-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.998; LPPFGQJSMHXOMT-UHFFFAOYSA-N; [M+H]+; 3-(4-acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-3-oxopropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; YJBYUBOFZKFXIH-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-(4-methylphenyl)imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.994; CWZAHGNWKZHUDH-UHFFFAOYSA-N; [M+H]+; 5,6-dimethyl-6-phenyl-3H-1,3,4-oxadiazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; CZEXVFFBZBDCNV-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-[(4-methoxyphenyl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; YRUROVCSGZJLIT-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-[(3-methoxyphenyl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; UZOJHXFWJFSFAI-VIFPVBQESA-N; [M+H]+; (3S)-3-benzylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; WRGKJJMOWIEJHK-UHFFFAOYSA-N; [M+H]+; 5-acetyl-1,3-dimethylbenzimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; WASRWSKUJBTVIY-UHFFFAOYSA-N; [M+H]+; 3-(3-aminophenyl)piperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; IRBLPZOXJHHXGE-UHFFFAOYSA-N; [M+H]+; 3-[(4-aminophenyl)methyl]pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; NEBGLASHEJDBJB-UHFFFAOYSA-N; [M+H]+; [4-(2-cyanoethyl)phenyl] N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.959; NPIUYHJLQXOYFZ-UHFFFAOYSA-N; [M+H]+; N-(benzylcarbamoyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; RTMDEHNRMKFSML-UHFFFAOYSA-N; [M+H]+; 5-methyl-5-(4-methylphenyl)imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; HHQAGLBRUUDKPF-UHFFFAOYSA-N; [M+H]+; 5-(1-phenylethyl)imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; DWFAULYVAZKKPX-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)benzimidazole-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; YAEXYISATSGZDB-UHFFFAOYSA-N; [M+H]+; 5,5-dimethyl-3-phenylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; XRPGEEYBQKPKSC-UHFFFAOYSA-N; [M+H]+; 1,3,4,5-tetrahydro-[1,4]oxazepino[4,3-a]benzimidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; DDORSJSRAREODY-UHFFFAOYSA-N; [M+H]+; 2,3,3-trimethyl-5-nitroindole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; DRNRLINOMGTASW-UHFFFAOYSA-N; [M+H]+; 4-(3,4-dihydro-2H-pyrrol-5-ylamino)benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; KTSRARHGUNNUMM-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-4-(1H-imidazol-5-ylmethyl)phenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; QVLABDVFFKPPGN-UHFFFAOYSA-N; [M+H]+; 3-(2-hydroxyethyliminomethyl)-1H-indol-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; LQJYZFQAQTXZEZ-RUDMXATFSA-N; [M+H]+; methyl (E)-2-cyano-3-(3,4-dimethyl-1H-pyrrol-2-yl)prop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.927; IGHKAKINXSIIIN-UHFFFAOYSA-N; [M+H]+; methyl 2-(4-cyanoanilino)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.927; AGXPRVBEODFHTN-UHFFFAOYSA-N; [M+H]+; methyl 3-amino-1-methylindole-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; ZDHBKJAJFVSOSF-UHFFFAOYSA-N; [M+H]+; 4-(1H-benzimidazol-2-yl)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; FPNXFJVIMBJDBY-UHFFFAOYSA-N; [M+H]+; methyl 2-(5-aminoindol-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; ISXUGEHIFOOHIF-UHFFFAOYSA-N; [M+H]+; methyl 2-(6-aminoindol-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; SDNKQPDFZPDDLZ-UHFFFAOYSA-N; [M+H]+; 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; LRJIDSGEYCYJHT-UHFFFAOYSA-N; [M+H]+; 1-(4-amino-2-methylphenyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; LEACTTGAGLHMFQ-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-2-methylphenyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; YNBGGUBQXVTLST-UHFFFAOYSA-N; [M+H]+; methyl 2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; WBGHUVVRWWHCDW-DHZHZOJOSA-N; [M+H]+; (4E)-4-(nitromethylidene)-1,2,3,5-tetrahydro-3-benzazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; PGVXBSSEVQUMQM-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-6-(1H-imidazol-5-ylmethyl)phenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; RFHMRCAOOQCCTE-UHFFFAOYSA-N; [M+H]+; 2-cyanopropan-2-yl N-phenylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; YADJEVFNQHNUSD-XNWCZRBMSA-N; [M+H]+; (E)-N-carbamoyl-2-phenylbut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; NDTIIGDOZXVDOY-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-1-(5-methyl-1,2-oxazol-3-yl)pyrrole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; KYNMONSTYCGIDJ-VIFPVBQESA-N; [M+H]+; (2S)-2-amino-3-(1H-indol-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; PVUWKCFXEZIILU-UHFFFAOYSA-N; [M+H]+; 3-amino-2-(1H-indol-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; CPBRIAKAVYPATC-UHFFFAOYSA-N; [M+H]+; spiro[3,4-dihydro-1,4-benzoxazepine-2,3'-azetidine]-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; CDWFDLYRKQOGNR-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; YUGKGJUVLVOHGK-UHFFFAOYSA-N; [M+H]+; 4-(1-hydroxy-2-imidazol-1-ylethyl)phenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; JJSHYECKYLDYAR-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)-5-phenyl-1,3-oxazol-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; NOQQYOLOKNTPKK-UHFFFAOYSA-N; [M+H]+; 1-[(4-aminophenyl)methyl]pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; CNBYMDSUCXNDIT-UHFFFAOYSA-N; [M+H]+; ethyl 7-amino-1H-indole-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; GQXOMZRZCLHBSH-UHFFFAOYSA-N; [M+H]+; ethyl 3-amino-1H-indole-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; KXEKODJGRSIGAU-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-1H-indole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; JHTBIGMLTCRRNA-UHFFFAOYSA-N; [M+H]+; ethyl 2-aminoindolizine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.843; CWBPDAREDFJTOB-UHFFFAOYSA-N; [M+H]+; ethyl 2-indazol-1-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; JTVPWPDLKUQDAU-UHFFFAOYSA-N; [M+H]+; ethyl 2-(1H-benzimidazol-2-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; FLAQFBICEAEEOA-UHFFFAOYSA-N; [M+H]+; ethyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; CELPSGSLQYBSCR-UHFFFAOYSA-N; [M+H]+; ethyl 2-imidazo[1,2-a]pyridin-2-ylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; QQNQPNGPSKOQAD-UHFFFAOYSA-N; [M+H]+; ethyl 2-(benzimidazol-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; YTJSIWPRJRFNGA-UHFFFAOYSA-N; [M+H]+; ethyl 2-methyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.839; BJSOSHBGDPCFLO-UHFFFAOYSA-N; [M+H]+; 4-(4-isocyanatophenyl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; RZDNXBOXSFUJAK-UHFFFAOYSA-N; [M+H]+; 2-[(dimethylamino)methyl]isoindole-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; WADHXSHSHULALT-UHFFFAOYSA-N; [M+H]+; 5-(2-phenylethyl)imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; OTTCLTLOYAZCAZ-UHFFFAOYSA-N; [M+H]+; 2-[2-(methylamino)ethyl]isoindole-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; QMERMWACWLHWSF-UHFFFAOYSA-N; [M+H]+; 3-ethyl-2-methyl-5-nitro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; FNECVBKHCBVTJM-UHFFFAOYSA-N; [M+H]+; 4-(2-methyl-1-nitropropan-2-yl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; PUSNHMVHJYSGME-UHFFFAOYSA-N; [M+H]+; [3-(4-methoxyphenyl)-1,2-oxazol-5-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; JEVVHEACJGXPMC-UHFFFAOYSA-N; [M+H]+; [5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; KLGTYFNPHMEIJY-UHFFFAOYSA-N; [M+H]+; [5-(3-methoxyphenyl)-1,2-oxazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.815; YYYJCGRRDMDFPQ-UHFFFAOYSA-N; [M+H]+; 6-amino-3-(cyclopropylmethyl)-1,3-benzoxazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; OVLKYXWCLMCKIB-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-(4-ethoxyphenyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; LVYLVSVOBJBWGV-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-(2-phenoxyethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; ZMRDIMNPBUPLPJ-UHFFFAOYSA-N; [M+H]+; 2-(1,3-benzodioxol-5-ylmethyl)-4,5-dihydro-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.453; KZPRCESDIPAEAE; [M+H]+; Phenyl-azo-acetylaceton
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.685; JBJKAGOWIZGVTR; [M+H]+; 3-hydroxymethylantipyrine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.248; AWQPZXNYDGBBOU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.944; SKVPTPMWXJSBTF; [M+H]+; Prestwick_270
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.502; CSZOHYLMFSLLFZ; [M+H]+; Oprea1_583180
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.488; CGSKTFVSAVYFAX; [M+H]+; 2-acetamido-3-phenylprop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.858; QMERMWACWLHWSF; [M+H]+; Oprea1_247831
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.234; SQIQIYYPWAELAC; [M+H]+; 1-propan-2-ylbenzimidazole-5-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.280; RFHMRCAOOQCCTE; [M+H]+; Ambcb5477156
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.058; FNECVBKHCBVTJM; [M+H]+; 4-(2-methyl-1-nitropropan-2-yl)benzonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.534; YKNPPZPHWDKZHL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.853; ZLCHKGJHNUULJZ; [M+H]+; 2,5-Pyrrolidinedione, 1-(methylphenylamino)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.300; BGWJSTZPSPZPFY; [M+H]+; 6,7-Dmomq
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.655; YAEXYISATSGZDB; [M+H]+; 5,5-Dimethyl-3-phenylhydantoin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.027; QQNQPNGPSKOQAD; [M+H]+; Ethyl 1H-benzimidazoleacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.060; GQXOMZRZCLHBSH; [M+H]+; Oprea1_396376
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.846; YADJEVFNQHNUSD; [M+H]+; 2-Phenylcrotonyl urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.737; FBFCBNWVKOBJLV; [M+H]+; 1-(para-Methoxy)phenyl-3-methyl-5-pyrazolone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.552; UUQQGGWZVKUCBD; [M+H]+; 2-Phenyl-4,5-dihydroxymethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.931; OTQKJRWGUZUOHM; [M+H]+; 5-amino-N-methyl-2-prop-2-ynoxybenzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.131; NHUPEUMBGMETKD; [M+H]+; Metazamidum
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.687; JTVPWPDLKUQDAU; [M+H]+; ethyl 2-benzimidazol-2-ylacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.006; JRXGAWVXJUVHTD; [M+H]+; Oprea1_026491
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.097; RTMDEHNRMKFSML; [M+H]+; Oprea1_127394
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.178; PVVTWNMXEHROIA; [M+H]+; 2-(3-hydroxypropyl)-1H-quinazolin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.589; UDUWINCMIJQMRI; [M+H]+; N-[(1-methoxyindol-3-yl)methyl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.850; ZDHBKJAJFVSOSF; [M+H]+; Oprea1_208955
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.221; CDWFDLYRKQOGNR; [M+H]+; Oprea1_033425
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.262; HCFFIJQLMJZMRX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.120; NXJZQAOQHFVDJW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.198; IXIODNUPYPVUBO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.316; UFSQOUQSBQLCPI; [M+H]+; 2,5-Dimethylimidazo(1,2-a)pyridine-3-acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.135; LVYLVSVOBJBWGV; [M+H]+; 2-Cyano-N-(2-phenoxyethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.413; USEXFCNJGSTLPE; [M+H]+; 3-methyl-6-phenylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.129; RZDNXBOXSFUJAK; [M+H]+; Oprea1_509724
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.373; KZEJQPGHFLYWOJ; [M+H]+; N-(3-oxo-1,4-dihydroisoquinolin-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.201; JEVVHEACJGXPMC; [M+H]+; (5-(4-Methoxyphenyl)isoxazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.722; AHGHATWVADBICH; [M+H]+; 4-Isopropyl-3-phenylsydnone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.929; KEKBLIAQVPGFMT; [M+H]+; CBMicro_013234
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.977; QIVBCDIJIAJPQS; [M+H]+; Pacitron
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.959; UDTWZFJEMMUFLC; [M+H]+; Nirvanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.220; ISKLKIWPGSGBNF; [M+H]+; 5-Methoxyindole-3-acetamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.108; FKIQEBMKCDEDBS; [M+H]+; Oprea1_730071
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.318; QZCFVHVWQOHXHZ; [M+H]+; 3-Ethyl-N-hydroxy-2-benzofurancarboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.102; BJSOSHBGDPCFLO; [M+H]+; Morpholine,4-(4-isocyanatophenyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.336; QVLABDVFFKPPGN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.739; NEBGLASHEJDBJB; [M+H]+; Stauffer R-10632
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.440; DLHWPLFJAJCANU; [M+H]+; Oprea1_280279
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.409; RDFZQTDLGKFDNB; [M+H]+; 5,6-dimethoxyquinolin-8-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.600; BUCXEFZXWKUCCY; [M+H]+; 3-(2-Phenylethyl)-4-methylsydnone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.039; UZVYGOXJMRZJFK; [M+H]+; Amiquinsin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.234; UAYIYEKRCXWKAR; [M+H]+; hydroxymethylphenyldihydropyridazinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.411; CELPSGSLQYBSCR; [M+H]+; Ethyl imidazo[1,2-a]pyridin-2-ylacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.366; BOCATKBAKISRLA; [M+H]+; 4-propyl-5-pyridin-4-yl-3H-oxazol-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.759; YYYJCGRRDMDFPQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.643; JLSMWTJTTSMNRP; [M+H]+; 3-(2-hydroxyethyl)-2-methylpyrido[1,2-a]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.176; YNBGGUBQXVTLST; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.333; RAGSBUDIXSABRI; [M+H]+; Oprea1_427579
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.477; UZOJHXFWJFSFAI; [M+H]+; 3-benzylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.000; WBGHUVVRWWHCDW; [M+H]+; 5-20-07-00131 (Beilstein Handbook Reference)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.913; KTSRARHGUNNUMM; [M+H]+; 2-(hydroxymethyl)-4-(1H-imidazol-5-ylmethyl)phenol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.953; PGVXBSSEVQUMQM; [M+H]+; Ledazerol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -358.599; CWZAHGNWKZHUDH; [M+H]+; 5,6-dimethyl-6-phenyl-3H-1,3,4-oxadiazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.111; WIMRYHOZLBQVIW; [M+H]+; (3,4-dihydroquinolin-2-ylamino)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.073; SZQIFWWUIBRPBZ; [M+H]+; ethotoin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.296; JJSHYECKYLDYAR; [M+H]+; Stimsen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -374.843; UGBXGEPGAPVHGY; [M+H]+; 3-(dimethylaminomethylidene)-5-hydroxy-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.009; RXOIEVSUURELPG; [M+H]+; Ordinator
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -396.812; HOZQRLDSYOOAJM; [M+H]+; Acide (methyl-4 phenyl)-3 delta-2 pyrazoline carboxylique-5
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.466; NSWKXPYAEDMRAW; [M+H]+; 2(1H)-Isoquinolineacetonitrile, 3,4-diydro-6,7-dihydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -409.229; MXAUKXXHSHERRL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -410.615; YPWANZCXVOBHHZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -416.298; LMAYKAKDOYDPIY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -419.649; KPYXDIVTPWLGHB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -435.765; MUKCVLFJCGZPKF; [M+H]+; methyl[(5-(3-pyridyloxy)(2-furyl))methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -439.068; ITGCPUVLXUYSOK; [M+H]+; (+) 11- Oxocitisine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -453.225; IGPJOUIOWWRVIN; [M+H]+; 4-oxido-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-4-ium-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -470.983; LHCOSZIUDMOCHW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -479.673; LNHYOBLZAGKVCY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -485.390; FIKUEZUFASUKAH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -486.559; FHYQNLDFRUPJAP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -492.700; HPMRFMKYPGXPEP; [M+H]+; Idazoxane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -494.427; WEFMOGRHGUPGMA; [M+H]+; Vasicinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -496.264; LUOCZSSCKBGSBD; [M+H]+; 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-3,6-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.157; KZPRCESDIPAEAE; [M+H]+; Phenyl-azo-acetylaceton
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.864; SKVPTPMWXJSBTF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.007; JEJITTKZWUYXKM; [M+H]+; o-Hydroxyantipyrine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.032; ZCZGFAAEKJPNPI; [M+H]+; 1,5-Dimethyl-3-oxidooxy-2-phenylpyrazol-2-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.442; LHDZEMJXRKBOEB; [M+H]+; p-Hydroxyantipyrine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.834; CGSKTFVSAVYFAX; [M+H]+; 2-acetamido-3-phenylprop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -184.131; KZPRCESDIPAEAE; [M+H]+; 3-Phenylazoacetylacetone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.965; JBJKAGOWIZGVTR; [M+H]+; 3-Hydroxymethylantipyrine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.335; AWQPZXNYDGBBOU; [M+H]+; 3-(Phenylhydrazono)-pentane-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -212.565; CSZOHYLMFSLLFZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -215.582; YADJEVFNQHNUSD; [M+H]+; (Z)-N-carbamoyl-2-phenylbut-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.242; SKVPTPMWXJSBTF; [M+H]+; nan
COMMENT: CONFIDENCE Level 5: Exact mass of interest 205.097152; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 5.345
MS$FOCUSED_ION: PRECURSOR_M/Z 205.097152
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0pb9-0390000000-b27dc4f673ebed9a0e04
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  58.0652979 11.7351 ? 58.066018 0.9472 4.87 -0.0270 17
  80.9450726 18.4661 ? 80.945799 0.9266 5.07 0.3495 17
  91.0542103 18.2093 ? 91.054890 1.3179 4.98 0.3235 17
  118.0651435 27.2150 ? 118.065601 1.2197 7.62 0.5931 17
  119.0855100 30.6054 ? 119.085958 0.9489 10.16 0.0464 18
  122.0600285 22.4139 ? 122.060448 1.0159 6.05 0.4912 16
  139.9820528 23.8468 ? 139.982327 1.0073 7.91 0.1893 15
  145.0759655 22.8316 ? 145.076253 1.2476 5.77 0.8848 17
  147.0804144 49.3880 ? 147.080707 1.0063 17.73 -0.1620 18
  148.0632417 13.4628 ? 148.063537 1.4453 3.87 0.4549 14
  163.0865422 154.6492 ? 163.086879 0.4108 10.89 0.9670 18
  164.0901113 11.8480 ? 164.090451 1.2737 1.64 0.8901 14
  172.0628954 14.9260 ? 172.063259 1.3658 4.25 0.6308 14
  174.0913852 18.1183 ? 174.091754 1.1833 6.01 0.3471 16
  187.0865610 124.4872 ? 187.086969 0.7323 12.81 0.9360 18
  188.1068043 70.1779 ? 188.107216 1.2918 18.85 0.5074 17
  189.1146925 123.1295 ? 189.115107 0.6081 28.39 0.6409 18
  190.0736788 32.2844 ? 190.074096 1.3048 13.01 0.9118 17
  194.9436056 22.9759 ? 194.944039 1.1029 6.87 0.2835 14
  204.1382607 758.0673 ? 204.138701 0.3037 160.97 0.7792 18
  204.9279708 23.7331 ? 204.928409 1.3956 7.82 0.2882 16
  205.0971962 999.0000 ? 205.097634 0.3608 38.41 1.0000 18
  206.1006475 105.8594 ? 206.101083 0.8637 10.59 0.9546 18
  206.1902951 14.4953 ? 206.190731 1.5132 6.53 0.0681 14
PK$NUM_PEAK: 24
PK$PEAK: m/z int. rel.int.
  58.065298 11.74 11
  80.945073 18.47 18
  91.054210 18.21 18
  118.065144 27.21 27
  119.085510 30.61 30
  122.060029 22.41 22
  139.982053 23.85 23
  145.075965 22.83 22
  147.080414 49.39 49
  148.063242 13.46 13
  163.086542 154.65 154
  164.090111 11.85 11
  172.062895 14.93 14
  174.091385 18.12 18
  187.086561 124.49 124
  188.106804 70.18 70
  189.114692 123.13 123
  190.073679 32.28 32
  194.943606 22.98 22
  204.138261 758.07 758
  204.927971 23.73 23
  205.097196 999.00 999
  206.100648 105.86 105
  206.190295 14.50 14
//
